:: CLDF ::

1.	Integrative analysis of serum proteomics and transcriptomics in hepatitis C.
	Wang, Jianqiong (J);Xia, Andong (A);Tang, Min (M);Yang, Shengjun (S);Shen, Yandi (Y);Dao, Jinhua (J);Tao, Rui (R);Yue, Wei (W);

2.	Offering is not enough: an attempt to increase infectious diseases testing at a large county jail in Massachusetts.
	Grussing, Emily D (ED);Sato, Taisuke (T);Cabrera, Alyssa (A);Wurcel, Alysse G (AG);

3.	Initial Real-World Pilot of the MedMorph Reference Architecture: Hepatitis C Surveillance and Research.
	Michaels, Maria (M);Botts, Nathan E (NE);Hassell, Susan (S);Mardon, Russell (R);Pan, Eric Chung Ren (ECR);Flanigan, Mike (M);Chehab, Chirine (C);Liu, Sara (S);Bocour, Angelica (A);Alexander, Mark (M);Aponte, Angel (A);Thompson, Nicola D (ND);

4.	Changes in the presentation and characteristics OF HCV related hepatocellular carcinoma in the era of direct acting antiviral therapy: A retrospective study.
	Abdelmoneim, Randa Salah (RS);Sedki, Fathalla (F);Bakosh, Mohamed Fathy (MF);

5.	The impact of restricted community accessibility on needle and syringe sharing among drug users in Baise city: based on the event study method.
	Li, Xujiao (X);Tan, Lanfen (L);Chen, Jian (J);Zhang, Ruchen (R);Zeng, Weide (W);Liu, Chang (C);Xie, Mengyao (M);Liang, Wangjin (W);Liang, Xu (X);Qi, Guangzi (G);

Curr Gastroenterol Rep.?2025 Feb 28;27(1):18.?doi: 10.1007/s11894-024-00955-3.

Qual Life Res.?2025 Feb 28.?doi: 10.1007/s11136-025-03922-1.?Online ahead of print.

J Acquir Immune Defic Syndr.?2025 Feb 20.?doi: 10.1097/QAI.0000000000003646.Online ahead of print.

Obstet Gynecol.?2025 Feb 27.?doi: 10.1097/AOG.0000000000005872.?Online ahead of print.

10.

Viruses.?2025 Feb 14;17(2):265.?doi: 10.3390/v17020265.

11.	The interplay of socio-demographic factors and disease prevalence: insights into malaria, Hepatitis B, and Hepatitis C in Lafia, Nasarawa State, Nigeria.
	Aremu, Dorcas Oluwakemi (DO);Maxim, Antipov (A);Aremu, Stephen Olaide (SO);Aremu, Damilola Esther (DE);Terhemen, Yakubu Daniel (YD);Itodo, Samuel Olusegun (SO);Barkhadle, Abdillahi Abdi (AA);

12.	Finding the Context of High-Risk Behavioral Factors and the Effectiveness of Addiction Treatment Centers in Preventing the Transmission of Hepatitis C Virus Among Injecting Drug Addicts: "Southeastern Iran".
	Asadi, Neda (N);Pourkhajoei, Sirous (S);

13.	Hepatitis C virus seroprevalence in defined populations in New Zealand: data from a general practice-based screening programme.
	Tiong, Ho Tuan (HT);Upton, Arlo (A);Lockie, Angelle (A);Moore, Kirsty (K);Stedman, Catherine A M (CAM);

14.

Immunol Res.?2025 Feb 21;73(1):55.?doi: 10.1007/s12026-025-09608-7.

15.

BMJ Open Gastroenterol.?2025 Feb 11;12(1):e001593.doi: 10.1136/bmjgast-2024-001593.

16.

Thorac Cardiovasc Surg.?2025 Mar;169(3):932-940.?doi: 10.1016/j.jtcvs.2024.06.025.Epub 2024 Jun 28.

17.

Hepatology.?2025 Mar 1;81(3):1006-1018.?doi: 10.1097/HEP.0000000000000923.Epub 2024 May 20.

18.	Dried blood spot as alternative specimen for molecular epidemiology studies among HCV/HIV coinfected patients.
	Flores, Geane (G);Lago, Barbara Vieira (BV);Caetano, Amanda R (AR);Silva, Jessica (J);Marques, Vanessa (V);Brandão-Mello, Carlos Eduardo (CE);Amendola-Pires, Marcia (M);Pilotto, Jose (J);Lewis-Ximenez, Lia (L);Villar, Livia Melo (LM);

19.	Trends of the incidence rate of Hepatitis C in Changsha, China, 2005 to 2023 and Its Prediction to 2025.
	Chen, Shuilian (S);Zeng, Ping (P);Yang, Kewei (K);Zhang, Xixing (X);Yang, Xuewen (X);Zhou, Yinzhu (Y);